CovidChloroV1, Main, Exploration, bibRecord, 000752

Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.

Identifieur interne : 000752 ( Main/Exploration ); précédent : 000751; suivant : 000753

Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.

Auteurs : Simone Sukhdeo [États-Unis] ; Emily Negroponte [États-Unis] ; Hariprem Rajasekhar [États-Unis] ; Sunanda Gaur [États-Unis] ; Daniel B. Horton [États-Unis] ; Amisha Malhotra [États-Unis] ; L Nandini Moorthy [États-Unis]

Source :

Lupus [ 1477-0962 ] ; 2021.

RBID : pubmed:33509065

Descripteurs français

KwdFr :
- Antiviraux (usage thérapeutique), Cytokines (antagonistes et inhibiteurs), Enfant d'âge préscolaire (MeSH), Glucocorticoïdes (usage thérapeutique), Humains (MeSH), Immunosuppresseurs (usage thérapeutique), Lupus érythémateux disséminé (complications), Lupus érythémateux disséminé (immunologie), Lupus érythémateux disséminé (traitement médicamenteux), Mâle (MeSH), Énoxaparine (usage thérapeutique), Évolution de la maladie (MeSH).
MESH :
- antagonistes et inhibiteurs : Cytokines.
- immunologie : Lupus érythémateux disséminé.
- traitement médicamenteux : Lupus érythémateux disséminé.
- usage thérapeutique : Antiviraux, Glucocorticoïdes, Immunosuppresseurs, Lupus érythémateux disséminé, Énoxaparine.
- Enfant d'âge préscolaire, Humains, Mâle, Évolution de la maladie.

English descriptors

KwdEn :
- Antiviral Agents (therapeutic use), COVID-19 (complications), COVID-19 (drug therapy), COVID-19 (immunology), Child, Preschool (MeSH), Cytokine Release Syndrome (drug therapy), Cytokine Release Syndrome (etiology), Cytokine Release Syndrome (immunology), Cytokines (antagonists & inhibitors), Disease Progression (MeSH), Enoxaparin (therapeutic use), Glucocorticoids (therapeutic use), Humans (MeSH), Immunosuppressive Agents (therapeutic use), Lupus Erythematosus, Systemic (complications), Lupus Erythematosus, Systemic (drug therapy), Lupus Erythematosus, Systemic (immunology), Male (MeSH), Respiratory Distress Syndrome (drug therapy), Respiratory Distress Syndrome (etiology), Respiratory Distress Syndrome (immunology), SARS-CoV-2 (MeSH).
MESH :
- chemical , antagonists & inhibitors : Cytokines.
- chemical , therapeutic use : Antiviral Agents, Enoxaparin, Glucocorticoids, Immunosuppressive Agents.
- complications : COVID-19, Lupus Erythematosus, Systemic.
- drug therapy : COVID-19, Cytokine Release Syndrome, Lupus Erythematosus, Systemic, Respiratory Distress Syndrome.
- etiology : Cytokine Release Syndrome, Respiratory Distress Syndrome.
- immunology : COVID-19, Cytokine Release Syndrome, Lupus Erythematosus, Systemic, Respiratory Distress Syndrome.
- Child, Preschool, Disease Progression, Humans, Male, SARS-CoV-2.

Abstract

We report a case of COVID-19 in a pediatric patient with systemic lupus erythematosus (SLE), who presented with respiratory distress marked by increased work of breathing and low oxygen saturation. Lab tests confirmed COVID-19, and showed lymphocytopenia and elevated markers of inflammation and coagulopathy. Chest X-ray showed bilateral mid-lung opacities, and the patient required intubation early in his disease course. Imaging and clinical findings were consistent with acute respiratory distress syndrome (ARDS) with inflammation. The patient was treated with different combinations of antivirals (hydroxychloroquine and remdesivir), cytokine inhibitors (anakinra and tocilizumab), glucocorticoids (hydrocortisone and methylprednisolone), and an anticoagulant (enoxaparin). Inflammatory markers decreased before clinical improvement in lung aeration. This case highlights the potential for pediatric patients with SLE to present with COVID-19 similar to the clinical presentation described in adults.

DOI: 10.1177/0961203321989791
PubMed: 33509065

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000429
to stream Main, to step Curation: 000429

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.</title>
<author><name sortKey="Sukhdeo, Simone" sort="Sukhdeo, Simone" uniqKey="Sukhdeo S" first="Simone" last="Sukhdeo">Simone Sukhdeo</name>
<affiliation wicri:level="2"><nlm:affiliation>Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Rutgers Robert Wood Johnson Medical School, Piscataway, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Negroponte, Emily" sort="Negroponte, Emily" uniqKey="Negroponte E" first="Emily" last="Negroponte">Emily Negroponte</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rajasekhar, Hariprem" sort="Rajasekhar, Hariprem" uniqKey="Rajasekhar H" first="Hariprem" last="Rajasekhar">Hariprem Rajasekhar</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gaur, Sunanda" sort="Gaur, Sunanda" uniqKey="Gaur S" first="Sunanda" last="Gaur">Sunanda Gaur</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Horton, Daniel B" sort="Horton, Daniel B" uniqKey="Horton D" first="Daniel B" last="Horton">Daniel B. Horton</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Malhotra, Amisha" sort="Malhotra, Amisha" uniqKey="Malhotra A" first="Amisha" last="Malhotra">Amisha Malhotra</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moorthy, L Nandini" sort="Moorthy, L Nandini" uniqKey="Moorthy L" first="L Nandini" last="Moorthy">L Nandini Moorthy</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33509065</idno>
<idno type="pmid">33509065</idno>
<idno type="doi">10.1177/0961203321989791</idno>
<idno type="wicri:Area/Main/Corpus">000429</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000429</idno>
<idno type="wicri:Area/Main/Curation">000429</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000429</idno>
<idno type="wicri:Area/Main/Exploration">000429</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.</title>
<author><name sortKey="Sukhdeo, Simone" sort="Sukhdeo, Simone" uniqKey="Sukhdeo S" first="Simone" last="Sukhdeo">Simone Sukhdeo</name>
<affiliation wicri:level="2"><nlm:affiliation>Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Rutgers Robert Wood Johnson Medical School, Piscataway, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Negroponte, Emily" sort="Negroponte, Emily" uniqKey="Negroponte E" first="Emily" last="Negroponte">Emily Negroponte</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rajasekhar, Hariprem" sort="Rajasekhar, Hariprem" uniqKey="Rajasekhar H" first="Hariprem" last="Rajasekhar">Hariprem Rajasekhar</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gaur, Sunanda" sort="Gaur, Sunanda" uniqKey="Gaur S" first="Sunanda" last="Gaur">Sunanda Gaur</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Horton, Daniel B" sort="Horton, Daniel B" uniqKey="Horton D" first="Daniel B" last="Horton">Daniel B. Horton</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Malhotra, Amisha" sort="Malhotra, Amisha" uniqKey="Malhotra A" first="Amisha" last="Malhotra">Amisha Malhotra</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moorthy, L Nandini" sort="Moorthy, L Nandini" uniqKey="Moorthy L" first="L Nandini" last="Moorthy">L Nandini Moorthy</name>
<affiliation wicri:level="2"><nlm:affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Lupus</title>
<idno type="eISSN">1477-0962</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>COVID-19 (complications)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (immunology)</term>
<term>Child, Preschool (MeSH)</term>
<term>Cytokine Release Syndrome (drug therapy)</term>
<term>Cytokine Release Syndrome (etiology)</term>
<term>Cytokine Release Syndrome (immunology)</term>
<term>Cytokines (antagonists & inhibitors)</term>
<term>Disease Progression (MeSH)</term>
<term>Enoxaparin (therapeutic use)</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Lupus Erythematosus, Systemic (complications)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Lupus Erythematosus, Systemic (immunology)</term>
<term>Male (MeSH)</term>
<term>Respiratory Distress Syndrome (drug therapy)</term>
<term>Respiratory Distress Syndrome (etiology)</term>
<term>Respiratory Distress Syndrome (immunology)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term>
<term>Cytokines (antagonistes et inhibiteurs)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Glucocorticoïdes (usage thérapeutique)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Lupus érythémateux disséminé (complications)</term>
<term>Lupus érythémateux disséminé (immunologie)</term>
<term>Lupus érythémateux disséminé (traitement médicamenteux)</term>
<term>Mâle (MeSH)</term>
<term>Énoxaparine (usage thérapeutique)</term>
<term>Évolution de la maladie (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Cytokines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Enoxaparin</term>
<term>Glucocorticoids</term>
<term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Cytokines</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>COVID-19</term>
<term>Lupus Erythematosus, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
<term>Cytokine Release Syndrome</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Respiratory Distress Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cytokine Release Syndrome</term>
<term>Respiratory Distress Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lupus érythémateux disséminé</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>COVID-19</term>
<term>Cytokine Release Syndrome</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Respiratory Distress Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lupus érythémateux disséminé</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Glucocorticoïdes</term>
<term>Immunosuppresseurs</term>
<term>Lupus érythémateux disséminé</term>
<term>Énoxaparine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Child, Preschool</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Male</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Enfant d'âge préscolaire</term>
<term>Humains</term>
<term>Mâle</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report a case of COVID-19 in a pediatric patient with systemic lupus erythematosus (SLE), who presented with respiratory distress marked by increased work of breathing and low oxygen saturation. Lab tests confirmed COVID-19, and showed lymphocytopenia and elevated markers of inflammation and coagulopathy. Chest X-ray showed bilateral mid-lung opacities, and the patient required intubation early in his disease course. Imaging and clinical findings were consistent with acute respiratory distress syndrome (ARDS) with inflammation. The patient was treated with different combinations of antivirals (hydroxychloroquine and remdesivir), cytokine inhibitors (anakinra and tocilizumab), glucocorticoids (hydrocortisone and methylprednisolone), and an anticoagulant (enoxaparin). Inflammatory markers decreased before clinical improvement in lung aeration. This case highlights the potential for pediatric patients with SLE to present with COVID-19 similar to the clinical presentation described in adults.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33509065</PMID>
<DateCompleted><Year>2021</Year>
<Month>04</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>04</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>30</Volume>
<Issue>5</Issue>
<PubDate><Year>2021</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Lupus</Title>
<ISOAbbreviation>Lupus</ISOAbbreviation>
</Journal>
<ArticleTitle>Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.</ArticleTitle>
<Pagination><MedlinePgn>836-839</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/0961203321989791</ELocationID>
<Abstract><AbstractText>We report a case of COVID-19 in a pediatric patient with systemic lupus erythematosus (SLE), who presented with respiratory distress marked by increased work of breathing and low oxygen saturation. Lab tests confirmed COVID-19, and showed lymphocytopenia and elevated markers of inflammation and coagulopathy. Chest X-ray showed bilateral mid-lung opacities, and the patient required intubation early in his disease course. Imaging and clinical findings were consistent with acute respiratory distress syndrome (ARDS) with inflammation. The patient was treated with different combinations of antivirals (hydroxychloroquine and remdesivir), cytokine inhibitors (anakinra and tocilizumab), glucocorticoids (hydrocortisone and methylprednisolone), and an anticoagulant (enoxaparin). Inflammatory markers decreased before clinical improvement in lung aeration. This case highlights the potential for pediatric patients with SLE to present with COVID-19 similar to the clinical presentation described in adults.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sukhdeo</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0001-9460-5200</Identifier>
<AffiliationInfo><Affiliation>Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Negroponte</LastName>
<ForeName>Emily</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rajasekhar</LastName>
<ForeName>Hariprem</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gaur</LastName>
<ForeName>Sunanda</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Horton</LastName>
<ForeName>Daniel B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo><Affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Malhotra</LastName>
<ForeName>Amisha</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moorthy</LastName>
<ForeName>L Nandini</ForeName>
<Initials>LN</Initials>
<AffiliationInfo><Affiliation>Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>01</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Lupus</MedlineTA>
<NlmUniqueID>9204265</NlmUniqueID>
<ISSNLinking>0961-2033</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword>
<Keyword MajorTopicYN="N">pediatric</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>29</Day>
<Hour>5</Hour>
<Minute>36</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33509065</ArticleId>
<ArticleId IdType="doi">10.1177/0961203321989791</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>New Jersey</li>
</region>
</list>
<tree><country name="États-Unis"><region name="New Jersey"><name sortKey="Sukhdeo, Simone" sort="Sukhdeo, Simone" uniqKey="Sukhdeo S" first="Simone" last="Sukhdeo">Simone Sukhdeo</name>
</region>
<name sortKey="Gaur, Sunanda" sort="Gaur, Sunanda" uniqKey="Gaur S" first="Sunanda" last="Gaur">Sunanda Gaur</name>
<name sortKey="Horton, Daniel B" sort="Horton, Daniel B" uniqKey="Horton D" first="Daniel B" last="Horton">Daniel B. Horton</name>
<name sortKey="Malhotra, Amisha" sort="Malhotra, Amisha" uniqKey="Malhotra A" first="Amisha" last="Malhotra">Amisha Malhotra</name>
<name sortKey="Moorthy, L Nandini" sort="Moorthy, L Nandini" uniqKey="Moorthy L" first="L Nandini" last="Moorthy">L Nandini Moorthy</name>
<name sortKey="Negroponte, Emily" sort="Negroponte, Emily" uniqKey="Negroponte E" first="Emily" last="Negroponte">Emily Negroponte</name>
<name sortKey="Rajasekhar, Hariprem" sort="Rajasekhar, Hariprem" uniqKey="Rajasekhar H" first="Hariprem" last="Rajasekhar">Hariprem Rajasekhar</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000752 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000752 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33509065
   |texte=   Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33509065" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.

Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki